Vladislav Leonov

Dr. Vladislav Leonov

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2026 in Bioactive Materials
Verified
Journal Article
Open access
DSDhavan Sharma
Dhavan Sharma
WJWenkai Jia
Wenkai Jia
ACAlvis Chiu
Alvis Chiu
HJHee Jae Jang
Hee Jae Jang
VLVladislav Leonov
Vladislav Leonov
Feng ZhaoFeng Zhao
Feng Zhao
Myocardial infarction (MI) remains a leading cause of heart failure due to the limited regenerative capacity of the adult myocardium. The therapeutic efficacy of current engineered cardiac patches is hindered by their simplistic scaffold composition and lack of structural organization. This study presents a bioactive, anisotropic extracellular matrix (ECM) scaffold derived from human induced pluripotent stem cell-differentiated cardiac fibroblasts (hiPSC-CF-ECM) that combines cardiac-specific proteins and growth factors with complex structural composition. Compared to primary cardiac fibroblast ECM (pri-CF-ECM) and human dermal fibroblast ECM (hDF-ECM), hiPSC-derived cardiomyocytes (hiPSC-CMs) cultured on the cardiac-specific ECM scaffold exhibited enhanced maturation, as confirmed by bulk RNA sequencing, electrophysiological mapping, and optical-based strain analysis. In an immune-competent rat MI model, the hiPSC-CF-ECM transplantation preserved cardiac function, increased ejection fraction, and reduced maladaptive remodeling. These findings highlight hiPSC-CF-ECM as a promising biomimetic scaffold for cardiac tissue engineering and MI treatment.

26 February 2025 in The Journal of Physiology
Verified
Journal Article
Open access
NMNeda Mohammadi
Neda Mohammadi
LFLaura Fedele
Laura Fedele
PCPoornaa Chakravarthy
Poornaa Chakravarthy
VLVladislav Leonov
Vladislav Leonov
LTLorenza Tsansizi
Lorenza Tsansizi
JSJose Luis Sanchez-Alonso
Jose Luis Sanchez-Alonso
The sympathetic nervous system densely innervates all cardiac chambers and is a key player in cardiac control, yet this relationship has scarcely been investigated using a stem cell‐based model. This study investigates the effects that sympathetic neurons (SNs) have on human pluripotent stem cell‐derived cardiomyocytes (hPSC‐CMs) in vitro, and whether they induce any degree of functional or structural maturity in these conventionally immature cells. SNs were isolated from neonatal rat pups, and cocultured with hPSC‐CMs for up to 15 days. Structural changes in hPSC‐CMs were analysed by microscopy techniques. Fluorescence resonance energy transfer was used to measure second messenger molecule cAMP production and β‐adrenergic receptor (βAR) response. Contractile and Ca2+ transient activity was measured using CytoCypher. These cocultures promoted hPSC‐CM structural elongation and increased sarcomere organization. Furthermore, the βAR response of cocultured hiPSC‐CMs was larger, indicated by increased cAMP production upon neuronal nicotinic stimulation. Faster contraction and ratiometric Ca2+ transient peak height and kinetic parameters strongly indicate increased chronotropic response in coculture. Coculture with SNs also elicited an increase in action potential amplitude and depolarization velocity, further confirming that SNs contribute to hiPSC‐CM functional maturation. Overall, we have found that SNs modulate hPSC‐CMs in vitro, inducing a more mature functional response. As an in vitro tool, these cocultures could serve as a model of sympathoadrenergic disease, enabling new discovery avenues. image Key points: The sympathetic nervous system controls the involuntary ‘fight‐or‐flight’ response, with the heart being one of key target organs. In certain neuro‐cardiac diseases, the input from the sympathetic nervous system is hyperregulated, and can lead to increased speed or force of the heart's contraction. Human induced pluripotent stem cells (hiPSCs) represent a rapidly evolving field which allow us to create a cell of interest and model its structural and functional activity in a dish. Here we have created hiPSC‐derived cardiomyocytes (hiPSC‐CMs) and cocultured them with sympathetic neurons (SNs). We found that SNs are able to modulate structure of the hiPSC‐CMs by reducing their circularity and increasing sarcomeric organization, and can significantly increase the speed of contraction and Ca2+ handling. Together, our data provide a platform to investigate the neuro‐cardiac relationship in vitro, which could be used for patient‐specific disease modelling in future.

6 October 2022 in CPT: Pharmacometrics & Systems Pharmacology
Verified
Journal Article
Open access
VLVladislav Leonov
Vladislav Leonov
EMEkaterina Mogilevskaya
Ekaterina Mogilevskaya
EGElita Gerasimuk
Elita Gerasimuk
NGNail Gizzatkulov
Nail Gizzatkulov
ODOleg Demin
Oleg Demin
Cell and cYTOkine CONcentrations DataBase (CYTOCON DB) is a project undertaken by the InSysBio team and aimed at the development of a database that allows collecting, processing, and visualizing publicly available in vivo human data on baseline concentrations of cells, cytokines, chemokines, and other molecules. Besides manual curation, an important feature of CYTOCON is that most values found in papers are converted from a huge variety of original units (i.e., mg/ml and number of cells per mm2 of biopsy surface section) to unified units: “pM” for cytokine and “kcell/L” for cell concentration. These features of the database can help researchers facilitate the creation and calibration of quantitative systems pharmacology (QSP) models. Possible applications can be: estimation of the average value or variability of the cell, cytokine or chemokine concentrations for patient groups with different characteristics, such as age, gender, disease severity, disease subtype, etc.; and analysis of correlations among the cell, cytokine, or chemokine concentrations in patients with different characteristics, such as severity of the disease.

4 December 2023 in Cells
Verified
Journal Article
Open access
PDF file
AJAleksandra Judina
Aleksandra Judina
MNMarili Niglas
Marili Niglas
VLVladislav Leonov
Vladislav Leonov
NKNicholas S. Kirkby
Nicholas S. Kirkby
IDIvan Diakonov
Ivan Diakonov
JGJulia Gorelik
Julia Gorelik
(1) Pulmonary hypertension (PH)-associated right ventricular (RV) failure is linked to a reduction in pulmonary vasodilators. Treprostinil has shown effectiveness in PAH patients with cardiac decompensation, hinting at potential cardiac benefits. We investigated treprostinil’s synergy with isoprenaline in RV and LV cardiomyocytes. We hypothesised that disease-related RV structural changes in cardiomyocytes would reduce contractile responses and cAMP/PKA signalling activity. (2) We induced PH in male Sprague Dawley rats using monocrotaline and isolated their ventricular cardiomyocytes. The effect of in vitro treprostinil and isoprenaline stimulation on contraction was assessed. FRET microscopy was used to study PKA activity associated with treprostinil stimulation in AKAR3-NES FRET-based biosensor-expressing cells. (3) RV cells exhibited maladaptive remodelling with hypertrophy, impaired contractility, and calcium transients compared to control and LV cardiomyocytes. Combining treprostinil and isoprenaline failed to enhance inotropy in PH RV cardiomyocytes. PH RV cardiomyocytes displayed an aberrant contractile behaviour, which the combination treatment could not rectify. Finally, we observed decreased PKA activity in treprostinil-treated PH RV cardiomyocytes. (4) PH-associated RV cardiomyocyte remodelling reduced treprostinil sensitivity, inotropic support, and impaired relaxation. Overall, this study highlights the complexity of RV dysfunction in advanced PH and suggests the need for alternative therapeutic strategies.

13 September 2024 in Circulation Research
Verified
Journal Article
Closed access
VLVladislav Leonov
Vladislav Leonov
TKTimothy Kamp
Timothy Kamp

2 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
VLVladislav Leonov
Vladislav Leonov
ETEleonora Torre
Eleonora Torre
CRCarlotta Ronchi
Carlotta Ronchi
Lia CrottiLia Crotti
Lia Crotti
Peter J. SchwartzPeter J. Schwartz
Peter J. Schwartz
LSLuca Sala
Luca Sala
The cardiac action potential (AP) is a key species-specific feature of cardiomyocytes that occurs in response to coordinated actions of ion channels. It represents the first step of the cardiac excitation-contraction coupling and it is crucial for cardiomyocyte (CM) physiology. Changes in the cardiac AP may primarily occur as a consequence of diseases or as a direct or unwanted response to drugs. Our ability to quantify these changes defines the reliability of our measurements and its throughput. Cardiac AP parameters are often quantified through manual time-consuming data analysis protocols or custom-made and proprietary data analysis pipelines; to the best of our knowledge, no tools are currently available for automated cardiac AP analysis and AP parameter quantification. Here we introduce a free and open source software tool named Batch Action PoTential Analyser (BAPTA), written in the R language, designed to i) overcome the inherent operator-dependent bias on trace selection affecting reproducibility, ii) vastly improve the throughput of the analyses of large datasets and iii) analyse both spontaneous and triggered APs from CMs of multiple species and origin. We present here four use-cases in which BAPTA can be used at high throughput to investigate the effects of: 1) a disease (cardiomyopathy) on rat CMs, 2) drugs on mouse pacemaker cells, 3) rate-dependency of AP duration in guinea pig CMs and 4) metabolic electrophysiological maturation in human stem-cell-derived CMs. Overall, BAPTA consistently provides faster, more reproducible and scalable readouts which excellently correlate with manual analyses performed by experienced electrophysiologists.